Adenosine Deamination sustains dendritic cell activation in inflammation

被引:109
作者
Desrosiers, Melanie D.
Cembrola, Katherine M.
Fakir, Michael J.
Stephens, Leslie A.
Jama, Fatimina M.
Shameli, Afshin
Mehal, Wajahat Z.
Santamaria, Pere
Shi, Yan
机构
[1] Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada
[3] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[4] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA
关键词
D O I
10.4049/jimmunol.179.3.1884
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenosine is a suppressive agent that protects the host from excessive tissue injury associated with strong inflammation. In tissue stress, higher levels of adenosine signal through adenosine receptors to exert strong anti-inflammatory effects, and thus protect host cells. Existing evidence also suggests that elevated adenosine potently down-regulates the activation of lymphocytes during inflammation. This notion, however, is in contrast with another basic observation that the immune system is highly activated precisely under the same circumstances against pathogens. In this study, we show that inflammatory responses of dendritic cells (DCs) are highly sensitive to adenosine suppression. However, they intrinsically carry high adenosine deaminase activity, which in turn degrades and removes adenosine from the surroundings, cutting off DCs from the suppression. This regulatory mechanism is important in DC responses to pathogen- associated molecular patterns and their activation of T cells. Our findings suggest a mechanism that DCs maintain their hyperreactive state in inflammation despite the general state of suppression, and reveal a regulatory role of adenosine deaminase in DC innate immune responses.
引用
收藏
页码:1884 / 1892
页数:9
相关论文
共 55 条
[1]   Progression of autoimmune diabetes driven by avidity maturation of a T-cell population [J].
Amrani, A ;
Verdaguer, J ;
Serra, P ;
Tafuro, S ;
Tan, RS ;
Santamaria, P .
NATURE, 2000, 406 (6797) :739-742
[2]   Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation [J].
Amrani, A ;
Serra, P ;
Yamanouchi, J ;
Trudeau, JD ;
Tan, RS ;
Elliott, JF ;
Santamaria, P .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :655-666
[3]   Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes [J].
Anderson, B ;
Park, BJ ;
Verdaguer, J ;
Amrani, A ;
Santamaria, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9311-9316
[4]   The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase [J].
Apasov, SG ;
Sitkovsky, MV .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (02) :179-189
[5]   SERUM AND PLEURAL ADENOSINE-DEAMINASE - CORRELATION WITH LYMPHOCYTIC POPULATIONS [J].
BAGANHA, MF ;
PEGO, A ;
LIMA, MA ;
GASPAR, EV ;
CORDEIRO, AR .
CHEST, 1990, 97 (03) :605-610
[6]   Adenosine deaminase deficiency: Metabolic basis of immune deficiency and pulmonary inflammation [J].
Blackburn, MR ;
Kellems, RE .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :1-41
[7]   Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency [J].
Blackburn, MR ;
Datta, SK ;
Kellems, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :5093-5100
[8]   The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: Established and putative beneficial actions of a retaliatory metabolite [J].
Bouma, MG ;
vandenWildenberg, FAJM ;
Buurman, WA .
SHOCK, 1997, 8 (05) :313-320
[9]  
BOUMA MG, 1994, J IMMUNOL, V153, P4159
[10]  
CHECHIK BE, 1981, J IMMUNOL, V126, P1003